Clinical trial
A Phase 1 Pharmacokinetic and Tolerability Study of Oral MLN9708 Plus Lenalidomide and Dexamethasone in Adult Asian Patients With Relapsed and/or Refractory Multiple Myeloma
NCT01645930 is registered in ClinicalTrials.gov with Millennium Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Pharmacokinetic and Tolerability Study of Oral MLN9708 Plus Lenalidomide and Dexamethasone in Adult Asian Patients With Relapsed and/or Refractory Multiple Myeloma
- Lead sponsor
- Millennium Pharmaceuticals, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 17, 2012
- Completion date
- April 11, 2017
- Enrollment
- 43 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.